Most prescriptions are filled in a "Unit Dose" dispensing system. Unit Dose dispensing reduces administration errors and saves nursing administration time. Unit Dose systems also offer safety and improved control relative to bulky systems used by retail pharmacies. In addition to filling prescriptions, Costless provides computerized medical records and documentation. This system of information management combined with the Unite Dose delivery system improves efficiency in nursing administration and reduces the likelihood of medication errors.

Over the last 22 years, Costless has gained experience not just in filling prescriptions, but in developing strategies that cut costs and improve outcomes. We customize programs to fit each facility, realizing that even within one state system, each facility would have separate needs. We have experience instituting plans that reduce paperwork and improve tracking. Our clinical pharmacists work closely with the facilities we serve to provide optimal care while reducing costs. Controlling costs requires accurate utilization reports that focus on various indicators such a percentage of residents on medications, number of medication per resident, etc. A comprehensive disease state expenditure analysis is prepared to inform the health care team which clinical areas are the most costly. This knowledge allows the facility to target the appropriate high-cost areas to effectively reduce expenditures.

Regulatory on-site pharmacist visits from a board certified Costless pharmacist ensure involvement of nursing staff as well as residents int he medication distribution process. Costless Senior Services also provides a Toll-Free telephone line for questions and one on one consultation opportunity.

To help save money for facilities and responsible parties, our consulting Pharmacists will substitute generic drugs approved for the equivalence by the Food and Drug Administration (FDA) if appropriate and when approved by the resident’s physician. In, addition therapeutic substitutions are made based on the recommendation of the Costless therapeutic formulary committee.